» Authors » Kyu Young Song

Kyu Young Song

Explore the profile of Kyu Young Song including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 466
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Giubellino A, He Y, Munro S, Zhou Y, Song K, Plaza J, et al.
Cancers (Basel) . 2024 May; 16(10). PMID: 38791877
Spitz and Spitzoid lesions represent one of the most challenging melanocytic neoplasms in dermatopathology. Nosologic classification has been more recently improved by the discovery of novel molecular drivers, particularly translocations....
2.
Song K, Han Y, Roehrich H, Brown M, Torres-Cabala C, Giubellino A
Cancers (Basel) . 2023 Jul; 15(13). PMID: 37444518
Melanoma is the leading cause of death from cutaneous malignancy. While targeted therapy and immunotherapy with checkpoint inhibitors have significantly decreased the mortality rate of this disease, advanced melanoma remains...
3.
Koo K, Wuenschmann A, Rendahl A, Song K, Forster C, Wolf-Ringwall A, et al.
Vet Sci . 2023 Apr; 10(4). PMID: 37104404
The overexpression and activation of the MET receptor tyrosine kinase has been identified in many human malignancies, but its role in canine cancer has only been minimally investigated. In this...
4.
Zhou Y, Nelson A, He Y, Munro S, Song K, Domingo-Musibay E, et al.
Genes (Basel) . 2022 Jan; 13(1). PMID: 35052351
BAP-1 (BRCA1-associated protein 1) inactivated melanocytic lesions are a group of familial or sporadic lesions with unique histology and molecular features. They are of great clinical interest, at least in...
5.
Giubellino A, Nelson A, He Y, Munro S, Song K, Glitza Oliva I, et al.
Pigment Cell Melanoma Res . 2021 Oct; 35(2):229-237. PMID: 34633770
Tumor heterogeneity is a relevant hallmark of melanoma due to the high mutation burden and immunogenicity commonly encountered. Heterogeneity at the histologic level frequently corresponds to heterogeneity at the molecular...
6.
Song K, Desar S, Pengo T, Shanley R, Giubellino A
Cancers (Basel) . 2020 Jul; 12(7). PMID: 32659961
The proto-oncogene MET, the hepatocyte growth factor (HGF) receptor, is a transmembrane receptor tyrosine kinase (RTK) with a prominent role in tumor metastasis and resistance to anti-cancer therapies. Melanoma demonstrates...
7.
Zhou Y, Song K, Giubellino A
Am J Pathol . 2019 Sep; 189(11):2138-2148. PMID: 31476283
Melanoma is the leading cause of death due to cutaneous malignancy and its incidence is on the rise. Several signaling pathways, including receptor tyrosine kinases, have been recognized to have...
8.
Zhang L, Kibaly C, Wang Y, Xu C, Song K, McGarrah P, et al.
EMBO Mol Med . 2017 Aug; 9(11):1521-1536. PMID: 28818835
Opiate withdrawal/negative reinforcement has been implicated as one of the mechanisms for the progression from impulsive to compulsive drug use. Increase in the intracellular cAMP level and protein kinase A...
9.
Lee D, Law P, Ln W, Loh H, Song K, Choi H
Biomed Rep . 2017 May; 6(5):532-538. PMID: 28529734
The Mu opioid receptor (MOR) mediates various functions of opioid-induced analgesia, euphoria and respiratory depression, and is a major target of opioid analgesics. Understanding of MOR gene expression among species...
10.
Song K, Choi H, Law P, Wei L, Loh H
J Cell Physiol . 2016 Jun; 232(3):576-584. PMID: 27292014
Expression of the mu-opioid receptor (MOR) protein is controlled by extensive transcriptional and post-transcriptional processing. MOR gene expression has previously been shown to be altered by a post-transcriptional mechanism involving...